Optical low–coherence reflectometry useful for biometric measurements

Article

The Lenstar LS 900 and applanation ultrasound can be used interchangeably for biometric measurement in cataract patients

The Lenstar LS 900 and applanation ultrasound can be used interchangeably for biometric measurement in cataract patients, according to a study published in Graefe's Archive for Clinical and Experimental Ophthalmology.

A team led by Dr Damir Bosnar, University Eye Clinic, University Hospital Sveti Duh, Croatia, compared the innovative non-contact optical low-coherence reflectometry (OLCR) method by the Lenstar LS 900 with applanation ultrasound to see if there was sufficient agreement in results of biometric measurements for intraocular lens (IOL) power calculations to warrant a replacement method.

Five consecutive measurements were performed on 32 eyes of 22 cataract patients. Applanation ultrasound and Lenstar IOL power calculation was based on both their automated keratometry and axial length measurements. Interobserver repeatability of applanation ultrasound and Lenstar was assessed by Bland-Altman analysis.

Predicted refractive error in 95%of observations was 0.26 ± 0.62 D with applanation ultrasound and 0.01± 0.20 D with Lenstar. The Lenstar demonstrated excellent repeatability and the applanation ultrasound showed acceptable repeatability.

The study suggested that OLCR could become an alternative method for biometric measurement for IOL power calculation in cataract patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.